trv027
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jul 31, 2020 (NCT04419610)
Timeline
Indications
Mechanism of action
AGTR1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04924660 | Phase 2/Phase 3 (Phase 3) | Jul 15, 2021 | National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Vanderbilt University |
| NCT04419610 | Early Phase 1 (Phase 1) | Jul 31, 2020 | Imperial College London, National Health Service, United Kingdom |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2020 |
| National Health Service, United Kingdom | Government | 1 | 0 | 1 | 2020 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2021 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2021 |
| Vanderbilt University | Academic/Hospital | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1